Ibrutinib is not an effective drug in primografts of...

Translational Oncology 2020 / 10 Vol. 13; Iss. 10

Ibrutinib is not an effective drug in primografts of TCF3-PBX1

van de Ven, Cesca, Boeree, Aurélie, Stalpers, Femke, Zwaan, C. Michel, Den Boer, Monique L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Translational Oncology
DOI:
10.1016/j.tranon.2020.100817
Date:
October, 2020
File:
PDF, 1.79 MB
2020
Conversion to is in progress
Conversion to is failed